1. Laboratory of Hematology, University of Liège, GIGA-I3, Liège, Belgium;
2. Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, University and CHU of Liège, Liège, Belgium;
3. Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology and Hematology, Wilhelminenspital, Vienna, Austria;
4. Division of Hematology, Department of Medicine, University and CHU of Liège, Liège, Belgium;
5. Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium